Background Pathology of the soft tissues of the shoulder including the musculotendinous rotator cuff and subacromial bursa are extremely common and are a principal cause of pain and suffering. Competing theories have been proposed to explain the pathoaetiology of rotator cuff pathology at specifi c stages and presentations of the condition. This review proposes a model to describe the continuum of the rotator cuff pathology from asymptomatic tendon through full thickness rotator cuff tears. Conclusions The pathoaetiology of rotator cuff failure is multifactorial and results from a combination of intrinsic, extrinsic and environmental factors. Recently a new and generic model detailing the continuum of tendon pathology has been proposed. This model is relevant for the rotator cuff and provides a framework to stage the continuity of rotator cuff pathology. Furthermore, it provides a structure to identify the substantial defi ciencies in our knowledge base and areas where research would improve our understanding of the pathological and repair process, together with assessment and management. The strength of this model adapted for the rotator cuff tendons and subacromial bursa will be tested in its ability to incorporate and adapt to emerging research.
INTRODUCTION
Certain sports place substantial demands on the shoulder. Elite swimmers execute approximately 2 million strokes per year, 1 2 and professional baseball pitchers generate ball speeds of up to 165 km/h with associated peak internal-rotation velocities up to 6940°/s. 3 4 These data elucidate why pathologies of the musculotendinous rotator cuff and subacromial bursa (SAB) are considered principal causes of shoulder pain. Various theories have been proposed to explain the pathogenesis of rotator cuff tendinopathy. These include tendon compression from extrinsic and intrinsic causes, tendon underuse and overuse, [5] [6] [7] [8] [9] [10] [11] genetics, 12 evolutionary adaptations 13 and nutrition. 14 15 To date, a defi nitive understanding of the pathoaetiology of rotator cuff tendinopathy has not been possible because of equivocal and insuffi cient research evidence. A review of anatomy, function and pathology of the rotator cuff has recently been published. 16 Cook and Purdam 17 recently presented a generic model to defi ne the continuum of tendon pathology. This new paradigm involves staging pathology chronologically within a clinical, histological and imaging framework. The continuum involves a transition from normal tendon to currently irreversible tendon pathology. Variations of the generic model may be required because of regional anatomical and/ or biomechanical considerations. The purpose of this review is to discuss the relevance of this new generic model with regard to rotator cuff tendinopathy and to propose management options for each of the stages described by Cook and Purdam. 17 
ROTATOR CUFF TENDINOPATHY: A NEW MODEL
The rotator cuff tendinopathy model (detailed in fi g 1) is based on the generic model presented by Cook and Purdam 17 and involves placing normal rotator cuff tendon as the optimal functional unit. This is defi ned as a structurally sound tendon that is pain-free and capable of performing the normal functional tasks required by the individual. Within this model, the tendon unit has the capacity to positively adapt to appropriate and graduated stress.
Underloaded tendon occurs when the rotator cuff does not receive appropriate physiological stress. Although this may occur throughout the tendon, its presence will be disproportionate and may affect the region of the rotator crescent and the articular side of the supraspinatus tendon. 18 19 With an appropriate stimulus, an underloaded tendon may return to become a normal tendon. Tendon underuse may result in an imbalance of matrix metalloproteinases (MMPs) and their inhibitors (tissue inhibitors of MMP (TIMPs)), which may eventuate in tendon degradation. Imaging (ultrasound (US) and MRI) investigations may reveal age-and activity-related structural pathology, which in this stage of the continuum may remain asymptomatic. The normal rotator cuff tendon and the underloaded tendon, if subject to an activity level in excess of that normally placed on the tendon, may subject the tissue to overload. If the overload is transient, which may be identifi ed on MRI as in an increase in tendon volume due to increased bound water content, the tendon may return to its preloaded state. This state termed normal tendon overload is painfree and is a normal response to loading rotator cuff tissue through activity and exercise.
However, the increased volume under the coracoacromial arch may potentially increase the strain in the coracoacromial ligament. Because of its trapezoidal shape and the relatively smaller surface area on the acromial side, strain within the ligament may potentially lead to the development of acromial traction spurs. The development of these osteophytes may depend on load and the anatomy of the region. 20 Continuous loading in this state may have an either positive or negative effect on the tendon. This will depend on the intensity, volume and frequency of the load applied to the tendon. If applied in a graduated and controlled manner, the loading will lead to a tendon capable of withstanding greater stress.
If the applied load exceeds the physiological capacity of the rotator cuff, the effect may be tendon upregulation. The fi rst stage may be reactive tendinopathy and is predominantly seen in an acutely overloaded tendon. This stage may involve the SAB tissue, where abnormal neuropeptide (substance P) and cytokine levels have been reported. 21 22 Although there may be no substantial areas of tendon degeneration, there will be increased swelling within the tendon, and it possibly involves bursal effusion. Cook and Purdam 17 have suggested that this stage occurs following a burst of unaccustomed activity and exists as a transition phase between normal tendon and tendon disrepair. This stage is probably driven by an increased activation of tenocytes, whose fi rst response is driving a deposition of proteoglycans with larger molecular weight such as aggrecan.
Pain may be present, and this may be constant or intermittent and probably position and activity dependent. Constant pain and/or night pain may further implicate the SAB. 23 In this stage, failure of the rotator cuff to control superior translation of the humeral head may lead to a secondary irritation of the superior fi bres of the tendon against the coracoacromial ligament and the undersurface of the acromion. 24 Because of the upregulation of the vascular endothelial growth factor in the early stages of rotator cuff tendon overuse, 16 neovascularity may be present.
Cook and Purdam 17 defi ned the next stage in the continuum as tendon disrepair. This will involve essentially the same spectrum of clinical symptoms as reactive tendinopathy. The symptoms may be more commonly associated with movement and activity. Tendon disrepair may be characterised by substantial areas of swelling, tendon degeneration, hypoechoic areas on greyscale US imaging that correspond with disorganisation of the matrix, increases in ground substance and some separation of the collagen fi bres. It will also be observed as swelling and increased signal on MRI. A bursal reaction characterised by effusion and areas of neovascularity within the tendon and bursa may be present. The presence of neovascularity may be more evident if examined with the tendon off stretch, following an activity or after heating.
Cook and Purdam 17 have classifi ed the fi nal stage as degenerated tendon, and for the rotator cuff, this will be associated with substantial structural failure in the form of large partial-thickness, full-thickness and massive rotator cuff tears. 25 In the late stages, there may also be radiological evidence of glenohumeral and acromial degenerative changes.
STAGING TREATMENT WITHIN THIS MODEL
Patient education, pain reduction, tendon load management (unloading and reloading) and re-injury prevention form the basis of symptomatic rotator cuff tendon rehabilitation. In addition to this, consideration should be given to the possibility of SAB involvement associated with the presenting symptoms. To maintain optimal health and function, tendons require appropriate ongoing mechanical stimulation. Chronically underloaded tendon in a sedentary population may result in asymptomatic degeneration and tears, which will increase with age. This may occur as a result of alterations in the concentrations of the MMPs and TIMPs. It is not currently understood why elite-level athletes develop asymptomatic rotator cuff pathology. 26 It may be due to overuse or fl uctuating periods of activity and relative rest infl uencing MMP and TIMP concentrations. It may also be due to the relatively low innervation in tendons that do not produce a pain response in the presence of structural pathology until a specifi c threshold is reached. Treatment for an underloaded rotator cuff involves a tendon-reloading programme in a controlled and graduated manner. The management for a structurally and functionally normal rotator cuff involves maintenance of physical activity with appropriate controlled and graduated increase in tendon loading as required. To maximise the benefi t of tendon-loading 
activities, the load, duration and intensity of activity placed on the rotator cuff tendons must be carefully controlled, structured and monitored.
Load reduction, together with pain management, is a key component in the management of reactive tendinopathy. Evidence-based guidance is not currently available. One suggestion requiring vigorous scientifi c enquiry would be to reduce activity level to control pain to a level of 1 to 2 out of 10 (worst imaginable pain) on a visual analogue scale of pain. Additionally, during this period of relative rest, modalities, taping and manual therapy may be considered to reduce pain and restore shoulder movement and function. The inclusion of these procedures, at this stage of management, is not substantiated by defi nitive research evidence, and ongoing scientifi c enquiry is essential. Other methods of assessing the shoulder in order to determine possible management options, including pain reduction and restoration of movement, have been suggested. 27 The presence of intratendinous swelling is a potential feature of this stage of tendon pathology. Selective non-steroidal anti-infl ammatory drugs appear to inhibit tendon cell proliferation and matrix glycosaminoglycan synthesis, 28 and the synthesis of aggrecan may be inhibited by the non-steroidal anti-infl ammatory drug, ibuprofen. 29 Guided SAB injections may help reduce pain and improve function. 30 Uncertainty exists as to whether injections should include analgesic or analgesic and steroid. [31] [32] [33] Although yet to be substantiated, cryotherapy may also reduce swelling. Exercises to reduce superior migration of the humeral head on the glenoid fossa may be beneficial. High-load eccentric exercises and fast concentric/eccentric regimes should probably be avoided. Dietary changes may be benefi cial to improve tendon health and symptoms. 14 15 Ongoing pain management and the other components of management for reactive tendinopathy remain important components for the treatment of tendon disrepair. Graduated tendon reloading including concentric, isometric and eccentric exercise is introduced during this stage. Evidence exists that glenohumeral external and internal rotations have opposing effects on subacromial pressure 34 with external rotation lowering pressure. Additionally, exercises to depress the humeral head may also be warranted. 27 Failure of an exercise programme to achieve the desired outcome may necessitate other management options such as glyceryl trinitrate patches, 35 injection therapy and possibly surgery. Conservative treatment should generally be considered before surgical intervention. 36 37 All interventions require vigorous scientifi c investigation. Evidence exists from other regions that reducing the expression of neovascularity is associated with a reduction in tendon symptoms. 38 A number of therapeutic techniques such as cyrotherapy, thermal modalities and exercise may contribute to reducing neovascularity. The relationship between neovascularity and symptoms arising from rotator cuff tendon pathology and the SAB is yet to be established, and if a defi nitive correlation exists, then research designed to investigate the best methods of reducing the expression of neovascularity in a timely manner without resulting in short-or long-term tendon damage is required.
Pain control and restoring normal movement are the principal aims of managing degenerated tendon. 39 Clinical investigations have suggested that even in the presence of substantial structural pathology, range of movement and power may be improved when pain is reduced [40] [41] [42] and management options described for tendon disrepair are relevant for tendon degeneration. Another key factor that may positively infl uence outcome is the presence of a functioning rotator cable. 19 The decision to attempt a surgical repair of the tear should be informed on an assessment of the (1) individual patient's functional requirements, (2) size of the tear and (3) the amount of fat infi ltration into the muscle because the presence of fatty streaks has been associated with negative surgical outcomes. 43 44 Future advances in pharmacology, stem cell research and tendon grafts may lead to advances in the management of degenerated tendons and other aspects of the continuum of rotator cuff pathology. Table 1 summarises the continuum of rotator cuff pathology, with possible imaging fi ndings, clinical presentations and management options.
CONCLUSION
Recently, a new and generic model detailing the continuum of tendon pathology has been proposed. This model is relevant for the rotator cuff and provides a framework to stage the continuity of rotator cuff disease. Furthermore, it provides a structure to identify the substantial defi ciencies in our knowledge base and areas, where research would improve our understanding of the pathological and repair process, together with assessment and management. Cook and Purdam 17 have suggested that the strength of their generic model will be tested in its ability to incorporate and adapt to emerging research. This also applies for the rotator cuff tendinopathy continuum model presented in this paper.
